Treatment doctor tested on himself can put others into remission

Five years ago, David C. Fajgenbaum both a Penn Medicine researcher and patient, tried an experimental treatment for Castleman disease based on his laboratory research findings in the hopes of saving his own life. He has been in remission ever since.

Penn Today Staff

Mary Francis to head Penn Press

Mary Francis has been named director of Penn Press at the University of Pennsylvania, effective Sept. 23. The announcement was made today by Penn Provost Wendell Pritchett.

Leo Charney

Five questions with Kevin Mahoney

Kevin B. Mahoney, a 23-year veteran of Penn Medicine, became CEO of the University of Pennsylvania Health System on July 1. In a Q&A, Mahoney shares his expertise and inspiration on Penn Medicine’s strengths, where it can improve, and a little insight into his downtime.

Penn Today Staff

In the News

Philadelphia Inquirer

Vaping Study Earns $175,000 Prize for Chadds Ford Teen

Teen Research and Education in Environmental Science (TREES) scholar Natalia Orlovsky worked with mentor Jeffrey Field of the Perelman School of Medicine to research the effects of vaping on human lung cells.


The Verge

Crypto.com Is Not for Sale

After purchasing the domain name crypto.com in 1993, Matt Blaze of the School of Engineering and Applied Science has had to repeatedly fend off attempts by cryptocurrency enthusiasts to purchase the website for upwards of seven figures. Blaze has refused to sell, warning against the use of cryptocurrency as “investment vehicles.”